Indomethacin in pregnancy: Applications and safety

American Journal of Perinatology

Volumn 29, Issue 3, 2012, Pages 175-186

  Abou Ghannam, Gael ^a   Usta, Ihab M ^a   Nassar, Anwar H ^a  

^a AMERICAN UNIVERSITY OF BEIRUT   (Lebanon)

Author keywords

fetal side effects; indomethacin; polyhydramnios; preterm labor; short cervix; tocolysis

Indexed keywords

BETAMETHASONE; BUPHENINE; CELECOXIB; CYCLOOXYGENASE 2; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDOMETACIN; INTERLEUKIN 8; MAGNESIUM SULFATE; NIMESULIDE; PLACEBO; PROSTAGLANDIN SYNTHASE; PROSTAGLANDIN SYNTHASE INHIBITOR; RITODRINE; SULINDAC; SULTAMICILLIN; TERBUTALINE;

ARTICLE; BLEEDING TIME; BRAIN HEMORRHAGE; BRONCHOSPASM; CHRONIC KIDNEY FAILURE; CORTICOSTEROID THERAPY; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG HALF LIFE; DRUG HYPERSENSITIVITY; DRUG METABOLISM; DRUG PENETRATION; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; DYSPEPSIA; DYSPNEA; ENCEPHALOMALACIA; GASTRITIS; HUMAN; HYDRAMNIOS; KIDNEY FAILURE; LABOR; LIVER INJURY; LOADING DRUG DOSE; META ANALYSIS; NAUSEA; NECROTIZING ENTEROCOLITIS; NEUROPATHOLOGY; NEWBORN SEPSIS; NONHUMAN; OLIGOHYDRAMNIOS; OLIGURIA; PATENT DUCTUS ARTERIOSUS; PEPTIC ULCER; PERINATAL MORTALITY; PRACTICE GUIDELINE; PREMATURE LABOR; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS INHIBITION; PROTHROMBIN TIME; REPEATED DRUG DOSE; RESPIRATORY DISTRESS SYNDROME; SHORT CERVIX; SIDE EFFECT; STOMACH IRRITATION; TERATOGENICITY; TOCOLYSIS; UNSPECIFIED SIDE EFFECT; UTERINE CERVIX CERCLAGE; UTERINE CERVIX DISEASE; VOMITING;

CERCLAGE, CERVICAL; CEREBRAL HEMORRHAGE; DUCTUS ARTERIOSUS; ENTEROCOLITIS, NECROTIZING; FEMALE; FETUS; HUMANS; INDOMETHACIN; INFANT, NEWBORN; INFANT, PREMATURE, DISEASES; OBSTETRIC LABOR, PREMATURE; OLIGOHYDRAMNIOS; POLYHYDRAMNIOS; PREGNANCY; PREGNANCY COMPLICATIONS; TOCOLYTIC AGENTS;

EID: 84858799773     PISSN: 07351631     EISSN: 10988785     Source Type: Journal    
DOI: 10.1055/s-0031-1284227     Document Type: Article

References (168)

1. Paneth NS. The problem of low birth weight. Future Child: 1995; 5 19 34
2. Goldenberg RL, Culhane JF, Iams JD, Romero R. Epidemiology and causes of preterm birth. Lancet: 2008; 371 75 84
3. ACOG Committee on Practice BulletinsObstetrics. ACOG practice bulletin. Management of preterm labor. Number 43, May 2003. Int J Gynaecol Obstet: 2003; 82 127 135
4. Gordon MC, Samuels P. Indomethacin. Clin Obstet Gynecol: 1995; 38 697 705
5. Hui D, Liu G, Kavuma E, Hewson SA, McKay D, Hannah ME. Preterm labour and birth: a survey of clinical practice regarding use of tocolytics, antenatal corticosteroids, and progesterone. J Obstet Gynaecol Can: 2007; 29 117 130
6. Klauser CK, Briery CM, Magann EF, Martin RW, Chauhan SP, Morrison JC. Tocolytic preference for treatment of preterm labor. J Miss State Med Assoc: 2007; 48 35 38
7. Gamissans O, Balasch J. Prostaglandin synthetase inhibitors in the treatment of preterm birth. In: Fuchs A-R, Stubblefield PG, Fuchs F. eds. Preterm Birth: Causes, Prevention, and Management. 2nd ed. New York McGraw-Hill: 1993; 309 332
8. Niebyl JR, Blake DA, White RD., et al. The inhibition of premature labor with indomethacin. Am J Obstet Gynecol: 1980; 136 1014 1019 (Pubitemid 10112854)
9. Sawdy R, Knock GA, Bennett PR, Poston L, Aaronson PI. Effect of nimesulide and indomethacin on contractility and the Ca2 + channel current in myometrial smooth muscle from pregnant women. Br J Pharmacol: 1998; 125 1212 1217 (Pubitemid 28542529)
10. Allport VC, Pieber D, Slater DM, Newton R, White JO, Bennett PR. Human labour is associated with nuclear factor-kappaB activity which mediates cyclo-oxygenase-2 expression and is involved with the "functional progesterone withdrawal. o"Mol Hum Reprod: 2001; 7 581 586 (Pubitemid 32536878)
11. Allport VC, Slater DM, Newton R, Bennett PR. NF-kappaB and AP-1 are required for cyclo-oxygenase 2 gene expression in amnion epithelial cell line (WISH). Mol Hum Reprod: 2000; 6 561 565 (Pubitemid 30365803)
12. Elliott CL, Allport VC, Loudon JA, Wu GD, Bennett PR. Nuclear factor-kappa B is essential for up-regulation of interleukin-8 expression in human amnion and cervical epithelial cells. Mol Hum Reprod: 2001; 7 787 790 (Pubitemid 32734303)
13. Yin MJ, Yamamoto Y, Gaynor RB. The anti-inflammatory agents aspirin and salicylate inhibit the activity of I(kappa)B kinase-beta. Nature: 1998; 396 77 80 (Pubitemid 28520452)
14. Loudon JA, Groom KM, Bennett PR. Prostaglandin inhibitors in preterm labour. Best Pract Res Clin Obstet Gynaecol: 2003; 17 731 744 (Pubitemid 37173372)
15. O'Brien WF. The role of prostaglandins in labor and delivery. Clin Perinatol: 1995; 22 973 984 (Pubitemid 26010351)
16. Bry K, Hallman M. Prostaglandins, inflammation, and preterm labor. J Perinatol: 1989; 9 60 65
17. Dong YL, Gangula PR, Fang L, Yallampalli C. Differential expression of cyclooxygenase-1 and -2 proteins in rat uterus and cervix during the estrous cycle, pregnancy, labor and in myometrial cells. Prostaglandins: 1996; 52 13 34 (Pubitemid 26299822)
18. Steinborn A, Günes H, Halberstadt E. Signal for term parturition is of trophoblast and therefore of fetal origin. Prostaglandins: 1995; 50 237 252 (Pubitemid 26082602)
19. Rajabi MR, Cybulsky AV. Phospholipase A2 activity is increased in guinea pig uterine cervix in late pregnancy and at parturition. Am J Physiol: 1995; 269 5 Pt 1 E940 E947 (Pubitemid 3005912)
20. Teixeira FJ, Zakar T, Hirst JJ., et al. Prostaglandin endoperoxide-H synthase (PGHS) activity and immunoreactive PGHS-1 and PGHS-2 levels in human amnion throughout gestation, at term, and during labor. J Clin Endocrinol Metab: 1994; 78 1396 1402
21. Cox SM, King MR, Casey ML, MacDonald PC. Interleukin-1 beta, -1 alpha, and -6 and prostaglandins in vaginal/cervical fluids of pregnant women before and during labor. J Clin Endocrinol Metab: 1993; 77 805 815 (Pubitemid 23298671)
22. Parilla BV, Tamura RK, Cohen LS, Clark E. Lack of effect of antenatal indomethacin on fetal cerebral blood flow. Am J Obstet Gynecol: 1997; 176 1166 1169, discussion 1169-1171
23. Zuckerman H, Shalev E, Gilad G, Katzuni E. Further study of the inhibition of premature labor by indomethacin. Part II double-blind study. J Perinat Med: 1984; 12 25 29 (Pubitemid 14162418)
24. Morales WJ, Madhav H. Efficacy and safety of indomethacin compared with magnesium sulfate in the management of preterm labor: a randomized study. Am J Obstet Gynecol: 1993; 169 97 102 (Pubitemid 23223935)
25. Kurki T, Eronen M, Lumme R, Ylikorkala O. A randomized double-dummy comparison between indomethacin and nylidrin in threatened preterm labor. Obstet Gynecol: 1991; 78 1093 1097
26. Stika CS, Gross GA, Leguizamon G., et al. A prospective randomized safety trial of celecoxib for treatment of preterm labor. Am J Obstet Gynecol: 2002; 187 653 660
27. Morales WJ, Smith SG, Angel JL, O'Brien WF, Knuppel RA. Efficacy and safety of indomethacin versus ritodrine in the management of preterm labor: a randomized study. Obstet Gynecol: 1989; 74 567 572 (Pubitemid 19239772)
28. Panter KR, Hannah ME, Amankwah KS, Ohlsson A, Jefferies AL, Farine D. The effect of indomethacin tocolysis in preterm labour on perinatal outcome: a randomised placebo-controlled trial. Br J Obstet Gynaecol: 1999; 106 467 473 (Pubitemid 29201527)
29. Besinger RE, Niebyl JR, Keyes WG, Johnson TR. Randomized comparative trial of indomethacin and ritodrine for the long-term treatment of preterm labor. Am J Obstet Gynecol: 1991; 164 981 986, discussion 986-988
30. Macones GA, Marder SJ, Clothier B, Stamilio DM. The controversy surrounding indomethacin for tocolysis. Am J Obstet Gynecol: 2001; 184 264 272 (Pubitemid 32206969)
31. Doyle NM, Gardner MO, Wells L, Qualls C, Papile LA. Outcome of very low birth weight infants exposed to antenatal indomethacin for tocolysis. J Perinatol: 2005; 25 336 340 (Pubitemid 40645605)
32. Alvn G, Orme M, Bertilsson L, Ekstrand R, Palmr L. Pharmacokinetics of indomethacin. Clin Pharmacol Ther: 1975; 18 364 373
33. Bhat R, Vidyasagar D, Vadapalli M., et al. Disposition of indomethacin in preterm infants. J Pediatr: 1979; 95 313 316 (Pubitemid 9211129)
34. Insel P. Analgesic-antipyretic and anti-inflammatory agents and drugs employed in the treatment of gout. In: Hardman JG, Limbird LE, Molinoff PB, Ruddon RW, Gilman AG. eds. The Pharmacological Basis of Therapeutics. 9th ed. New York McGraw-Hill: 1996; 617 658
35. vd Heijden AJ, Provoost AP, Nauta J., et al. Renal functional impairment in preterm neonates related to intrauterine indomethacin exposure. Pediatr Res: 1988; 24 644 648 (Pubitemid 18266179)
36. Van den Veyver IB, Moise KJ Jr. Prostaglandin synthetase inhibitors in pregnancy. Obstet Gynecol Surv: 1993; 48 493 502
37. Fortson W, Beharry KD, Nageotte S., et al. Vaginal versus oral indomethacin in a rabbit model for non-infection-mediated preterm birth: an alternate tocolytic approach. Am J Obstet Gynecol: 2006; 195 1058 1064 (Pubitemid 44415664)
38. Abramov Y, Nadjari M, Weinstein D, Ben-Shachar I, Plotkin V, Ezra Y. Indomethacin for preterm labor: a randomized comparison of vaginal and rectal-oral routes. Obstet Gynecol: 2000; 95 482 486 (Pubitemid 30139564)
39. Locatelli A, Vergani P, Bellini P, Strobelt N, Ghidini A. Can a cyclo-oxygenase type-2 selective tocolytic agent avoid the fetal side effects of indomethacin? BJOG: 2001; 108 325 326 (Pubitemid 32210135)
40. Carlan SJ, O'Brien WF, O'Leary TD, Mastrogiannis D. Randomized comparative trial of indomethacin and sulindac for the treatment of refractory preterm labor. Obstet Gynecol: 1992; 79 223 228
41. King JF, Flenady V, Cole S, Thornton S. Cyclo-oxygenase (COX) inhibitors for treating preterm labour. Cochrane Database Syst Rev: 2005; 2 CD001992
42. Katz Z, Lancet M, Yemini M, Mogilner BM, Feigl A, Ben Hur H. Treatment of premature labor contractions with combined ritodrine and indomethacine. Int J Gynaecol Obstet: 1983; 21 337 342 (Pubitemid 13008959)
43. Bivins HA Jr, Newman RB, Fyfe DA, Campbell BA, Stramm SL. Randomized trial of oral indomethacin and terbutaline sulfate for the long-term suppression of preterm labor. Am J Obstet Gynecol: 1993; 169 1065 1070 (Pubitemid 23317556)
44. McWhorter J, Carlan SJ, OLeary TD, Richichi K, OBrien WF. Rofecoxib versus magnesium sulfate to arrest preterm labor: a randomized trial. Obstet Gynecol: 2004; 103 5 Pt 1 923 930 (Pubitemid 40458993)
45. Kramer WB, Saade GR, Belfort M, Dorman K, Mayes M, Moise KJ Jr. A randomized double-blind study comparing the fetal effects of sulindac to terbutaline during the management of preterm labor. Am J Obstet Gynecol: 1999; 180 2 Pt 1 396 401 (Pubitemid 29093874)
46. Schorr SJ, Ascarelli MH, Rust OA., et al. A comparative study of ketorolac (Toradol) and magnesium sulfate for arrest of preterm labor. South Med J: 1998; 91 1028 1032 (Pubitemid 28524384)
47. Eronen M, Pesonen E, Kurki T, Teramo K, Ylikorkala O, Hallman M. Increased incidence of bronchopulmonary dysplasia after antenatal administration of indomethacin to prevent preterm labor. J Pediatr: 1994; 124 5 Pt 1 782 788 (Pubitemid 24161473)
48. Gamissans O, Caas E, Cararach V, Ribas J, Puerto B, Edo A. A study of indomethacin combined with ritodrine in threatened preterm labor. Eur J Obstet Gynecol Reprod Biol: 1978; 8 123 128 (Pubitemid 8382869)
49. Spearing G. Alcohol, indomethacin, and salbutamol. A comparative trial of their use in preterm labor. Obstet Gynecol: 1979; 53 171 174 (Pubitemid 9066919)
50. Newton ER, Shields L, Ridgway LE III, Berkus MD, Elliott BD. Combination antibiotics and indomethacin in idiopathic preterm labor: a randomized double-blind clinical trial. Am J Obstet Gynecol: 1991; 165 6 Pt 1 1753 1759
51. Higby K, Xenakis EM, Pauerstein CJ. Do tocolytic agents stop preterm labor? A critical and comprehensive review of efficacy and safety. Am J Obstet Gynecol: 1993; 168 1247 1256, discussion 1256-1259
52. Vermillion ST, Landen CN. Prostaglandin inhibitors as tocolytic agents. Semin Perinatol: 2001; 25 256 262 (Pubitemid 32802732)
53. Haas DM, Imperiale TF, Kirkpatrick PR, Klein RW, Zollinger TW, Golichowski AM. Tocolytic therapy: a meta-analysis and decision analysis. Obstet Gynecol: 2009; 113 585 594
54. Tan TC, Devendra K, Tan LK, Tan HK. Tocolytic treatment for the management of preterm labour: a systematic review. Singapore Med J: 2006; 47 361 366
55. Berghella V, Iams JD, Newman RB., et al. National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units. Frequency of uterine contractions in asymptomatic pregnant women with or without a short cervix on transvaginal ultrasound scan. Am J Obstet Gynecol: 2004; 191 1253 1256 (Pubitemid 39421579)
56. Lewis D, Pelham JJ, Done E, Sawhney H, Talucci M, Berghella V. Uterine contractions in asymptomatic pregnant women with a short cervix on ultrasound. J Matern Fetal Neonatal Med: 2005; 18 325 328 (Pubitemid 43062380)
57. Vitoratos N, Hassiakos D, Louridas C, Limuris G, Zourlas PA. Prostaglandin F1a and prostaglandin E2 plasma levels after transvaginal cervical cerclage. Clin Exp Obstet Gynecol: 1996; 23 21 25
58. Visintine J, Airoldi J, Berghella V. Indomethacin administration at the time of ultrasound-indicated cerclage: is there an association with a reduction in spontaneous preterm birth? Am J Obstet Gynecol: 2008; 198 643, e1 e3
59. Berghella V, Prasertcharoensuk W, Cotter A., et al. Does indomethacin prevent preterm birth in women with cervical dilatation in the second trimester? Am J Perinatol: 2009; 26 13 19
60. Berghella V, Rust OA, Althuisius SM. Short cervix on ultrasound: does indomethacin prevent preterm birth? Am J Obstet Gynecol: 2006; 195 809 813 (Pubitemid 44292131)
61. Rust OA, Atlas RO, Reed J, van Gaalen J, Balducci J. Revisiting the short cervix detected by transvaginal ultrasound in the second trimester: why cerclage therapy may not help. Am J Obstet Gynecol: 2001; 185 1098 1105 (Pubitemid 33097371)
62. Althuisius SM, Dekker GA, Hummel P, Bekedam DJ, van Geijn HP. Final results of the Cervical Incompetence Prevention Randomized Cerclage Trial (CIPRACT): therapeutic cerclage with bed rest versus bed rest alone. Am J Obstet Gynecol: 2001; 185 1106 1112 (Pubitemid 33097372)
63. To MS, Alfirevic Z, Heath VC., et al. Fetal Medicine Foundation Second Trimester Screening Group. Cervical cerclage for prevention of preterm delivery in women with short cervix: randomised controlled trial. Lancet: 2004; 363 1849 1853 (Pubitemid 38748638)
64. Berghella V, Odibo AO, Tolosa JE. Cerclage for prevention of preterm birth in women with a short cervix found on transvaginal ultrasound examination: a randomized trial. Am J Obstet Gynecol: 2004; 191 1311 1317 (Pubitemid 39421590)
65. Kofinas A, Kofinas J. Indomethacin as a diagnostic and therapeutic tool in the management of progressive cervical shortening diagnosed by trans-vaginal sonography. J Matern Fetal Neonatal Med: 2011; 24 79 85
66. Jeyabalan A, Caritis SN. Pharmacologic inhibition of preterm labor. Clin Obstet Gynecol: 2002; 45 99 113 (Pubitemid 34212413)
67. Lunt CC, Satin AJ, Barth WH Jr, Hankins GD. The effect of indomethacin tocolysis on maternal coagulation status. Obstet Gynecol: 1994; 84 820 822 (Pubitemid 24329852)
68. Lissak A, Fruchter OH, Abramovici H. Uncommon adverse maternal effects with indomethacin for tocolysis. Int J Gynaecol Obstet: 1999; 67 183 185
69. Mari G, Moise KJ Jr, Deter RL, Kirshon B, Carpenter RJ. Doppler assessment of the renal blood flow velocity waveform during indomethacin therapy for preterm labor and polyhydramnios. Obstet Gynecol: 1990; 75 199 201 (Pubitemid 20062232)
70. Moise KJ Jr, Mari G, Kirshon B, Huhta JC, Walsh SW, Cano L. The effect of indomethacin on the pulsatility index of the umbilical artery in human fetuses. Am J Obstet Gynecol: 1990; 162 199 202 (Pubitemid 20055450)
71. Klein KL, Scott WJ, Clark KE, Wilson JG. Indomethacinplacental transfer, cytotoxicity, and teratology in the rat. Am J Obstet Gynecol: 1981; 141 448 452 (Pubitemid 11027005)
72. Traeger A, Nöschel H, Zaumseil J. [Pharmacokinetics of indomethacin in pregnant and parturient women and in their newborn infants]. Zentralbl Gynakol: 1973; 95 635 641
73. Norton ME, Merrill J, Cooper BA, Kuller JA, Clyman RI. Neonatal complications after the administration of indomethacin for preterm labor. N Engl J Med: 1993; 329 1602 1607 (Pubitemid 23345638)
74. Merrill JD, Clyman RI, Norton ME. Indomethacin as a tocolytic agent: the controversy continues. J Pediatr: 1994; 124 5 Pt 1 734 736 (Pubitemid 24161463)
75. Marpeau L, Bouillie J, Barrat J, Milliez J. Obstetrical advantages and perinatal risks of indomethacin: a report of 818 cases. Fetal Diagn Ther: 1994; 9 110 115 (Pubitemid 24051302)
76. Friedman S, Flidel-Rimon O, Steinberg M, Shinwell ES. Indomethacin tocolysis and white matter injury in preterm infants. J Matern Fetal Neonatal Med: 2005; 18 87 91 (Pubitemid 41527058)
77. Baerts W, Fetter WP, Hop WC, Wallenburg HC, Spritzer R, Sauer PJ. Cerebral lesions in preterm infants after tocolytic indomethacin. Dev Med Child Neurol: 1990; 32 910 918 (Pubitemid 20310737)
78. Iannucci TA, Besinger RE, Fisher SG, Gianopoulos JG, Tomich PG. Effect of dual tocolysis on the incidence of severe intraventricular hemorrhage among extremely low-birth-weight infants. Am J Obstet Gynecol: 1996; 175 4 Pt 1 1043 1046 (Pubitemid 26357980)
79. Weintraub Z, Solovechick M, Reichman B., et al. Israel Neonatal Network. Effect of maternal tocolysis on the incidence of severe periventricular/ intraventricular haemorrhage in very low birthweight infants. Arch Dis Child Fetal Neonatal Ed: 2001; 85 F13 F17
80. Ojala R, Ikonen S, Tammela O. Perinatal indomethacin treatment and neonatal complications in preterm infants. Eur J Pediatr: 2000; 159 153 155 (Pubitemid 30139938)
81. Souter D, Harding J, McCowan L, O'Donnell C, McLeay E, Baxendale H. Antenatal indomethacinadverse fetal effects confirmed. Aust N Z J Obstet Gynaecol: 1998; 38 11 16 (Pubitemid 28077482)
82. Gardner MO, Owen J, Skelly S, Hauth JC. Preterm delivery after indomethacin. A risk factor for neonatal complications? J Reprod Med: 1996; 41 903 906 (Pubitemid 27020757)
83. Vermillion ST, Scardo JA, Lashus AG, Wiles HB. The effect of indomethacin tocolysis on fetal ductus arteriosus constriction with advancing gestational age. Am J Obstet Gynecol: 1997; 177 256 259, discussion 259-261
84. Suarez RD, Grobman WA, Parilla BV. Indomethacin tocolysis and intraventricular hemorrhage. Obstet Gynecol: 2001; 97 921 925 (Pubitemid 32522489)
85. Ment LR, Oh W, Ehrenkranz RA., et al. Low-dose indomethacin and prevention of intraventricular hemorrhage: a multicenter randomized trial. Pediatrics: 1994; 93 543 550 (Pubitemid 24106595)
86. Ment LR, Oh W, Ehrenkranz RA., et al. Low dose indomethacin and extension of intraventricular hemorrhage. J Pediatr: 1994; 124 951 955
87. Leffler CW, Busija DW, Fletcher AM, Beasley DG, Hessler JR, Green RS. Effects of indomethacin upon cerebral hemodynamics of newborn pigs. Pediatr Res: 1985; 19 1160 1164 (Pubitemid 16257010)
88. Friedman Z, Whitman V, Maisels MJ, Berman W Jr, Marks KH, Vesell ES. Indomethacin disposition and indomethacin-induced platelet dysfunction in premature infants. J Clin Pharmacol: 1978; 18 272 279 (Pubitemid 8384295)
89. Vermillion ST, Newman RB. Recent indomethacin tocolysis is not associated with neonatal complications in preterm infants. Am J Obstet Gynecol: 1999; 181 5 Pt 1 1083 1086
90. Ment LR, Duncan CC, Ehrenkranz RA., et al. Randomized low-dose indomethacin trial for prevention of intraventricular hemorrhage in very low birth weight neonates. J Pediatr: 1988; 112 948 955
91. Bandstra ES, Montalvo BM, Goldberg RN., et al. Prophylactic indomethacin for prevention of intraventricular hemorrhage in premature infants. Pediatrics: 1988; 82 533 542
92. Yanowitz TD, Yao AC, Werner JC, Pettigrew KD, Oh W, Stonestreet BS. Effects of prophylactic low-dose indomethacin on hemodynamics in very low birth weight infants. J Pediatr: 1998; 132 28 34 (Pubitemid 28082527)
93. Ment LR, Stewart WB, Ardito TA, Huang E, Madri JA. Indomethacin promotes germinal matrix microvessel maturation in the newborn beagle pup. Stroke: 1992; 23 1132 1137
94. Loe SM, Sanchez-Ramos L, Kaunitz AM. Assessing the neonatal safety of indomethacin tocolysis: a systematic review with meta-analysis. Obstet Gynecol: 2005; 106 173 179 (Pubitemid 40898451)
95. Amin SB, Sinkin RA, Glantz JC. Metaanalysis of the effect of antenatal indomethacin on neonatal outcomes. Am J Obstet Gynecol: 2007; 197 486, e1 e10
96. Major CA, Lewis DF, Harding JA, Porto MA, Garite TJ. Tocolysis with indomethacin increases the incidence of necrotizing enterocolitis in the low-birth-weight neonate. Am J Obstet Gynecol: 1994; 170 1 Pt 1 102 106 (Pubitemid 24084039)
97. Restaino I, Kaplan BS, Kaplan P, Rosenberg HK, Witzleben C, Roberts N. Renal dysgenesis in a monozygotic twin: association with in utero exposure to indomethacin. Am J Med Genet: 1991; 39 252 257
98. Gloor JM, Muchant DG, Norling LL. Prenatal maternal indomethacin use resulting in prolonged neonatal renal insufficiency. J Perinatol: 1993; 13 425 427
99. Kaplan BS, Restaino I, Raval DS, Gottlieb RP, Bernstein J. Renal failure in the neonate associated with in utero exposure to non-steroidal anti-inflammatory agents. Pediatr Nephrol: 1994; 8 700 704
100. Cantor B, Tyler T, Nelson RM, Stein GH. Oligohydramnios and transient neonatal anuria: a possible association with the maternal use of prostaglandin synthetase inhibitors. J Reprod Med: 1980; 24 220 223 (Pubitemid 10114366)
101. Hickok DE, Hollenbach KA, Reilley SF, Nyberg DA. The association between decreased amniotic fluid volume and treatment with nonsteroidal anti-inflammatory agents for preterm labor. Am J Obstet Gynecol: 1989; 160 1525 1530, discussion 1530-1531
102. Goldenberg RL, Davis RO, Baker RC. Indomethacin-induced oligohydramnios. Am J Obstet Gynecol: 1989; 160 5 Pt 1 1196 1197 (Pubitemid 19144486)
103. Hill LM, Lazebnik N, Many A. Effect of indomethacin on individual amniotic fluid indices in multiple gestations. J Ultrasound Med: 1996; 15 395 399 (Pubitemid 26131804)
104. Hendricks SK, Smith JR, Moore DE, Brown ZA. Oligohydramnios associated with prostaglandin synthetase inhibitors in preterm labour. Br J Obstet Gynaecol: 1990; 97 312 316 (Pubitemid 20153683)
105. de Wit W, van Mourik I, Wiesenhaan PF. Prolonged maternal indomethacin therapy associated with oligohydramnios. Case reports. Br J Obstet Gynaecol: 1988; 95 303 305
106. Nishikubo T, Takahashi Y, Nakagawa Y., et al. Renal impairment in very low birthweight infants following antenatal indomethacin administration. Acta Paediatr Jpn: 1994; 36 202 206 (Pubitemid 24144003)
107. Itskovitz J, Abramovici H, Brandes JM. Oligohydramnion, meconium and perinatal death concurrent with indomethacin treatment in human pregnancy. J Reprod Med: 1980; 24 137 140 (Pubitemid 10133962)
108. Vanhaesebrouck P, Thiery M, Leroy JG., et al. Oligohydramnios, renal insufficiency, and ileal perforation in preterm infants after intrauterine exposure to indomethacin. J Pediatr: 1988; 113 738 743
109. Pomeranz A, Korzets Z, Dolfin Z, Eliakim A, Bernheim J, Wolach B. Acute renal failure in the neonate induced by the administration of indomethacin as a tocolytic agent. Nephrol Dial Transplant: 1996; 11 1139 1141 (Pubitemid 26182513)
110. Gleason CA, Clyman RI, Heymann MA, Mauray F, Leake R, Roman C. Indomethacin and patent ductus arteriosus: effects on renal function in preterm lambs. Am J Physiol: 1988; 254 1 Pt 2 F38 F44
111. Kirshon B, Moise KJ Jr, Mari G, Willis R. Long-term indomethacin therapy decreases fetal urine output and results in oligohydramnios. Am J Perinatol: 1991; 8 86 88
112. Sandruck JC, Grobman WA, Gerber SE. The effect of short-term indomethacin therapy on amniotic fluid volume. Am J Obstet Gynecol: 2005; 192 1443 1445
113. Sawdy RJ, Lye S, Fisk NM, Bennett PR. A double-blind randomized study of fetal side effects during and after the short-term maternal administration of indomethacin, sulindac, and nimesulide for the treatment of preterm labor. Am J Obstet Gynecol: 2003; 188 1046 1051 (Pubitemid 36530061)
114. Novy MJ. Effects of indomethacin on labor, fetal oxygenation, and fetal development in rhesus monkeys. Adv Prostaglandin Thromboxane Res: 1978; 4 285 300
115. Wurtzel D. Prenatal administration of indomethacin as a tocolytic agent: effect on neonatal renal function. Obstet Gynecol: 1990; 76 689 692 (Pubitemid 20322079)
116. Savage AH, Anderson BL, Simhan HN. The safety of prolonged indomethacin therapy. Am J Perinatol: 2007; 24 207 213
117. Butler-O'Hara M, D'Angio CT. Risk of persistent renal insufficiency in premature infants following the prenatal use of indomethacin for suppression of preterm labor. J Perinatol: 2002; 22 541 546 (Pubitemid 35244035)
118. Veersema D, de Jong PA, van Wijck JA. Indomethacin and the fetal renal nonfunction syndrome. Eur J Obstet Gynecol Reprod Biol: 1983; 16 113 121 (Pubitemid 13021025)
119. Miall LS, Henderson MJ, Turner AJ., et al. Plasma creatinine rises dramatically in the first 48 hours of life in preterm infants. Pediatrics: 1999; 104 e76
120. Eronen M, Pesonen E, Kurki T, Ylikorkala O, Hallman M. The effects of indomethacin and a beta-sympathomimetic agent on the fetal ductus arteriosus during treatment of premature labor: a randomized double-blind study. Am J Obstet Gynecol: 1991; 164 1 Pt 1 141 146
121. Moise KJ Jr. Effect of advancing gestational age on the frequency of fetal ductal constriction in association with maternal indomethacin use. Am J Obstet Gynecol: 1993; 168 1350 1353 (Pubitemid 23153270)
122. Moise KJ Jr, Huhta JC, Sharif DS., et al. Indomethacin in the treatment of premature labor. Effects on the fetal ductus arteriosus. N Engl J Med: 1988; 319 327 331
123. Rudolph AM, Heymann MA. Hemodynamic changes induced by blockers of prostaglandin synthesis in the fetal lamb in utero. Adv Prostaglandin Thromboxane Res: 1978; 4 231 237
124. Suarez VR, Thompson LL, Jain V., et al. The effect of in utero exposure to indomethacin on the need for surgical closure of a patent ductus arteriosus in the neonate. Am J Obstet Gynecol: 2002; 187 886 888 (Pubitemid 35178376)
125. Momma K, Takao A. In vivo constriction of the ductus arteriosus by nonsteroidal antiinflammatory drugs in near-term and preterm fetal rats. Pediatr Res: 1987; 22 567 572 (Pubitemid 18002064)
126. Reese J, Anderson JD, Brown N, Roman C, Clyman RI. Inhibition of cyclooxygenase isoforms in late- but not midgestation decreases contractility of the ductus arteriosus and prevents postnatal closure in mice. Am J Physiol Regul Integr Comp Physiol: 2006; 291 R1717 R1723 (Pubitemid 44904139)
127. Clyman RI, Chen YQ, Chemtob S., et al. In utero remolding of the fetal lamb ductus arteriosus. Vasa vasorum proliferation, neointimal formation, and cell death. Circulation: 2001; 103 1806 1812
128. Hammerman C, Glaser J, Kaplan M, Schimmel MS, Ferber B, Eidelman AI. Indomethacin tocolysis increases postnatal patent ductus arteriosus severity. Pediatrics: 1998; 102 E56
129. Karunasiri M, Nasbaum H, Pinheiro J. Tocolysis with indomethacin is associated with patent ductus arteriosus refractory to therapy. [abstract]. Pediatr Res: 1996; 39 221A
130. Räsänen J, Jouppila P. Fetal cardiac function and ductus arteriosus during indomethacin and sulindac therapy for threatened preterm labor: a randomized study. Am J Obstet Gynecol: 1995; 173 20 25
131. Kirshon B, Mari G, Moise KJ Jr, Wasserstrum N. Effect of indomethacin on the fetal ductus arteriosus during treatment of symptomatic polyhydramnios. J Reprod Med: 1990; 35 529 532 (Pubitemid 20165441)
132. Respondek M, Weil SR, Huhta JC. Fetal echocardiography during indomethacin treatment. Ultrasound Obstet Gynecol: 1995; 5 86 89
133. Niebyl JR, Witter FR. Neonatal outcome after indomethacin treatment for preterm labor. Am J Obstet Gynecol: 1986; 155 747 749 (Pubitemid 17178318)
134. Levy R, Matitiau A, Ben Arie A, Milman D, Or Y, Hagay Z. Indomethacin and corticosteroids: an additive constrictive effect on the fetal ductus arteriosus. Am J Perinatol: 1999; 16 379 383 (Pubitemid 30201737)
135. Momma K, Toyoshima K, Ito K., et al. Delayed neonatal closure of the ductus arteriosus following early in utero exposure to indomethacin in the rat. Neonatology: 2009; 96 69 79
136. Neu J, Wu-Wang CY. Eicosanoids in the developing gastrointestinal tract. Semin Perinatol: 1987; 11 22 30
137. Wallace JL, Cohen MM. Gastric mucosal protection with chronic mild restraint: role of endogenous prostaglandins. Am J Physiol: 1984; 247 2 Pt 1 G127 G132 (Pubitemid 14063080)
138. Peskar BM. On the synthesis of prostaglandins by human gastric mucosa and its modification by drugs. Biochim Biophys Acta: 1977; 487 307 314 (Pubitemid 8091075)
139. Meyers RL, Alpan G, Lin E, Clyman RI. Patent ductus arteriosus, indomethacin, and intestinal distension: effects on intestinal blood flow and oxygen consumption. Pediatr Res: 1991; 29 569 574
140. Parilla BV, Grobman WA, Holtzman RB, Thomas HA, Dooley SL. Indomethacin tocolysis and risk of necrotizing enterocolitis. Obstet Gynecol: 2000; 96 120 123 (Pubitemid 30336292)
141. Ramsey P, Ramin K, Derleth D., et al. Indomethacin tocolysis is not associated with an increased incidence of isolated bowel perforations in premature neonates. [abstract]. Am J Obstet Gynecol: 1997; 176 S45
142. Abbasi S, Gerdes JS, Sehdev HM, Samimi SS, Ludmir J. Neonatal outcome after exposure to indomethacin in utero: a retrospective case cohort study. Am J Obstet Gynecol: 2003; 189 782 785 (Pubitemid 37194105)
143. Loe SM, Sanchez-Ramos L, Kaunitz AM. Assessing the neonatal safety of indomethacin tocolysis: a systematic review with meta-analysis. Obstet Gynecol: 2005; 106 173 179 (Pubitemid 40898451)
144. Bustos R, Ballejo G, Giussi G, Rosas R, Isa JC. Inhibition of fetal lung maturation by indomethacin in pregnant rabbits. J Perinat Med: 1978; 6 240 245 (Pubitemid 9068203)
145. Macones GA, Robinson CA. Is there justification for using indomethacin in preterm labor? An analysis of neonatal risks and benefits. Am J Obstet Gynecol: 1997; 177 819 824 (Pubitemid 27516048)
146. Moise KJ Jr. Indomethacin therapy in the treatment of symptomatic polyhydramnios. Clin Obstet Gynecol: 1991; 34 310 318
147. Cabrol D, Landesman R, Muller J, Uzan M, Sureau C, Saxena BB. Treatment of polyhydramnios with prostaglandin synthetase inhibitor (indomethacin). Am J Obstet Gynecol: 1987; 157 422 426
148. Mamopoulos M, Assimakopoulos E, Reece EA, Andreou A, Zheng XZ, Mantalenakis S. Maternal indomethacin therapy in the treatment of polyhydramnios. Am J Obstet Gynecol: 1990; 162 1225 1229 (Pubitemid 20174044)
149. Kirshon B, Mari G, Moise KJ Jr. Indomethacin therapy in the treatment of symptomatic polyhydramnios. Obstet Gynecol: 1990; 75 202 205 (Pubitemid 20062233)
150. Lange IR, Harman CR, Ash KM, Manning FA, Menticoglou S. Twin with hydramnios: treating premature labor at source. Am J Obstet Gynecol: 1989; 160 552 557 (Pubitemid 19092128)
151. Gerson A, Roberts N, Colmorgen G, Maynard C, Slate W, Smith K. Treatment of polyhydramnios with indomethacin. Am J Perinatol: 1991; 8 97 98
152. Rosen DJ, Rabinowitz R, Beyth Y, Fejgin MD, Nicolaides KH. Fetal urine production in normal twins and in twins with acute polyhydramnios. Fetal Diagn Ther: 1990; 5 57 60
153. Ash K, Harman CR, Gritter H. TRAP sequencesuccessful outcome with indomethacin treatment. Obstet Gynecol: 1990; 76 5 Pt 2 960 962 (Pubitemid 20370794)
154. Malas HZ, Hamlett JD. Acute recurrent polyhydramniosmanagement with indomethacin. Br J Obstet Gynaecol: 1991; 98 583 587
155. Restaino I, Kaplan BS, Kaplan P, Rosenberg HK, Witzleben C, Roberts N. Renal dysgenesis in a monozygotic twin: association with in utero exposure to indomethacin. Am J Med Genet: 1991; 39 252 257
156. Faber BL. [Recurrent acute polyhydramnios treated with indomethacin]. S Afr Med J: 1990; 78 215 216 (Pubitemid 20294315)
157. Nordström L, Westgren M. Indomethacin treatment for polyhydramnios. Effective but potentially dangerous? Acta Obstet Gynecol Scand: 1992; 71 239 241
158. Mohen D, Newnham JP, D'Orsogna L. Indomethacin for the treatment of polyhydramnios: a case of constriction of the ductus arteriosus. Aust N Z J Obstet Gynaecol: 1992; 32 243 246
159. Dolkart LA, Eshwar KP, Reimers FT. Indomethacin therapy and chronic hemodialysis during pregnancy. A case report. J Reprod Med: 1992; 37 181 183
160. Deeny M, Haxton MJ. Indomethacin use to control gross polyhydramnios complicating triplet pregnancy. Br J Obstet Gynaecol: 1993; 100 281 282 (Pubitemid 23098355)
161. Carmona F, Martnez-Romn S, Mortera C, Puerto B, Cararach V, Iglesias X. Efficacy and safety of indomethacin therapy for polyhydramnios. Eur J Obstet Gynecol Reprod Biol: 1993; 52 175 180 (Pubitemid 24028509)
162. Moise KJ Jr. Polyhydramnios. Clin Obstet Gynecol: 1997; 40 266 279 (Pubitemid 27348929)
163. Abhyankar S, Salvi VS. Indomethacin therapy in hydramnios. J Postgrad Med: 2000; 46 176 178
164. Kramer WB, Van den Veyver IB, Kirshon B. Treatment of polyhydramnios with indomethacin. Clin Perinatol: 1994; 21 615 630 (Pubitemid 24284512)
165. Vigil-de Gracia PE, Campos-Rivera P, Lasso-de la Vega J. [Pregnancy complicated with symptomatic polyhydramnios: treatment with indomethacin]. Ginecol Obstet Mex: 1997; 65 21 26 (Pubitemid 27113257)
166. Cabrol D, Jannet D, Pannier E. Treatment of symptomatic polyhydramnios with indomethacin. Eur J Obstet Gynecol Reprod Biol: 1996; 66 11 15 (Pubitemid 26148787)
167. Kriplani A, Abbi M, Banerjee N, Roy KK, Takkar D. Indomethacin therapy in the treatment of polyhydramnios due to placental chorioangioma. J Obstet Gynaecol Res: 2001; 27 245 248 (Pubitemid 33121173)
168. Bondagji N, Manning FA, Martel J, Harman CR, Morrison I. Complete resolution of CMV-associated acute hydramnios by single large volume reduction amniocentesis and maternal indomethacin. A case report. Fetal Diagn Ther: 1996; 11 345 347 (Pubitemid 26319010)